Société Générale — M&A Activity 2021

Jun 16, 2021

National Storage Mechanism | Additional information

RNS Number : 0707C

Societe Generale SA

16 June 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.05 ordinary shares
Date of dealing	15/06/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	10,277,446	4.08	4,867	0.00
(2) Derivatives (other than options)	0	0.00	6,188,855	2.46
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*10,337,446	*4.10	6,193,722	2.46

* Include the holding of 60,000 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit GBP (Note 5)
Purchase	413	10.44
Purchase	207	10.43
Purchase	414	10.42
Purchase	58	10.43
Purchase	414	10.43
Purchase	250	10.44
Purchase	320	10.44
Purchase	468	10.44
Purchase	444	10.45
Purchase	8	10.43
Purchase	310	10.43
Purchase	288	10.44
Purchase	290	10.44
Purchase	270	10.43
Purchase	288	10.43
Purchase	340	10.44
Purchase	377	10.43
Purchase	325	10.43
Purchase	328	10.44
Purchase	829	10.45
Purchase	322	10.43
Purchase	337	10.44
Purchase	307	10.43
Purchase	184	10.43
Purchase	126	10.43
Purchase	310	10.44
Purchase	336	10.43
Purchase	33	10.43
Purchase	288	10.43
Purchase	178	10.44
Purchase	307	10.43
Purchase	330	10.42
Purchase	235	10.43
Purchase	213	10.43
Purchase	36	10.43
Purchase	333	10.44
Purchase	210	10.43
Purchase	325	10.43
Purchase	176	10.43
Purchase	144	10.44
Purchase	312	10.43
Purchase	164	10.44
Purchase	301	10.43
Purchase	316	10.43
Purchase	322	10.42
Purchase	340	10.42
Purchase	423	10.43
Purchase	829	10.43
Purchase	233	10.43
Purchase	710	10.43
Purchase	240	10.43
Purchase	351	10.43
Purchase	830	10.43
Purchase	337	10.42
Purchase	214	10.44
Purchase	256	10.44
Purchase	330	10.43
Purchase	326	10.43
Purchase	271	10.43
Purchase	829	10.43
Purchase	830	10.43
Purchase	239	10.44
Purchase	328	10.43
Purchase	237	10.43
Purchase	327	10.41
Purchase	312	10.44
Purchase	305	10.44
Purchase	304	10.43
Purchase	450	10.43
Purchase	241	10.43
Purchase	336	10.44
Purchase	304	10.43
Purchase	315	10.44
Purchase	54	10.43
Purchase	12,000	10.454585
Purchase	24,000	10.454585
Sale	250	10.42
Sale	563	10.42
Sale	726	10.42
Sale	346	10.43
Sale	73	10.43
Sale	22	10.43
Sale	250	10.43
Sale	56	10.43
Sale	55	10.43
Sale	66	10.43
Sale	918	10.47
Sale	207	10.44
Sale	999	10.43
Sale	204	10.43
Sale	256	10.44
Sale	449	10.42
Sale	3	10.43
Sale	3	10.43
Sale	15	10.44
Sale	296	10.44
Sale	3	10.43
Sale	3	10.43
Sale	221	10.43
Sale	148	10.43
Sale	36	10.43
Sale	4	10.43
Sale	3	10.43
Sale	3	10.43
Sale	3	10.43
Sale	3	10.43
Sale	392	10.43
Sale	356	10.43
Sale	11	10.44
Sale	66	10.44
Sale	309	10.44
Sale	60	10.43
Sale	146	10.43
Sale	15	10.43
Sale	504	10.43
Sale	19	10.43
Sale	79	10.43
Sale	91	10.43
Sale	22	10.43
Sale	634	10.43
Sale	32	10.43
Sale	241	10.43
Sale	156	10.42
Sale	340	10.42
Sale	357	10.42
Sale	837	10.43
Sale	401	10.43
Sale	305	10.43
Sale	14	10.44
Sale	294	10.44
Sale	1,712	10.44
Sale	3,501	10.44
Sale	264	10.44
Sale	833	10.44
Sale	1,394	10.42
Sale	263	10.44
Sale	441	10.43
Sale	231	10.43
Sale	324	10.43
Sale	112	10.42
Sale	334	10.42
Sale	110	10.44
Sale	691	10.44
Sale	305	10.44
Sale	500	10.43
Sale	25	10.43
Sale	459	10.43
Sale	636	10.43
Sale	131	10.43
Sale	324	10.42
Sale	13	10.42
Sale	400	10.43
Sale	362	10.43
Sale	775	10.43
Sale	1,169	10.44
Sale	187	10.41
Sale	140	10.41
Sale	340	10.43
Sale	15	10.43
Sale	26	10.43
Sale	321	10.43
Sale	22	10.43
Sale	13	10.44
Sale	294	10.44
Sale	372	10.43
Total Purchases	59,887
Total Sales	28,904

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit GBP (Note 5)
CFD	Increased short	12,000	10.454585
CFD	Increased short	24,000	10.454585

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements, or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	16/06/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEASKKFSNFEEA